Tessari Eben's Form 4 filing
Kiniksa Pharmaceuticals International, plc (KNSA) · filed Sep 3, 2025
- Accession no.
- 0001415889-25-023587
- Filed
- Sep 3, 2025
- Trade date
- Sep 1-3, 2025
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Checked
This filing lists 9 non-derivative transactions and 8 derivative transactions. Open-market sales total $535.7K. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Tessari EbenCIK 0001867899 | Officer (CHIEF OPERATING OFFICER) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Sep 1, 2025 | Class A Ordinary Share | MOption exerciseAcquired | +1,746 | – | – | 41,961 | Direct | |
| Sep 1, 2025 | Class A Ordinary Share | MOption exerciseAcquired | +1,773 | – | – | 43,734 | Direct | |
| Sep 1, 2025 | Class A Ordinary Share | MOption exerciseAcquired | +2,726 | – | – | 46,460 | Direct | |
| Sep 1, 2025 | Class A Ordinary Share | FTax withholdingDisposed | −3,022 | $33.49 | −$101,206.78 | 43,438 | Direct | |
| Sep 2, 2025 | Class A Ordinary Share | MOption exerciseAcquired | +1,964 | – | – | 45,402 | Direct | |
| Sep 2, 2025 | Class A Ordinary Share | FTax withholdingDisposed | −950 | $34.28 | −$32,566 | 44,452 | Direct | |
| Sep 3, 2025 | Class A Ordinary Share | MOption exerciseAcquired | +65 | $15.52 | +$1,008.8 | 44,517 | Direct | |
| Sep 3, 2025 | Class A Ordinary Share | MOption exerciseAcquired | +15,026 | $15.50 | +$232,903 | 59,543 | Direct | |
| Sep 3, 2025 | Class A Ordinary Share | SSaleDisposed | −15,091 | $35.50 | −$535,730.5 | 44,452 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Sep 1, 2025 | Class A Ordinary Share | AGrant or awardAcquired | +9,828 | $0.00 | $0 | 9,828 | Direct | |
| Sep 1, 2025 | Class A Ordinary Share | AGrant or awardAcquired | +39,364 | $0.00 | $0 | 39,364 | Direct | |
| Sep 1, 2025 | Class A Ordinary Share | MOption exerciseAcquired | +1,746 | $0.00 | $0 | 5,235 | Direct | |
| Sep 1, 2025 | Class A Ordinary Share | MOption exerciseDisposed | −1,773 | $0.00 | $0 | 3,545 | Direct | |
| Sep 1, 2025 | Class A Ordinary Share | MOption exerciseDisposed | −2,726 | $0.00 | $0 | 2,726 | Direct | |
| Sep 2, 2025 | Class A Ordinary Share | MOption exerciseDisposed | −1,964 | $0.00 | $0 | 0 | Direct | |
| Sep 3, 2025 | Class A Ordinary Share | MOption exerciseDisposed | −65 | $0.00 | $0 | 59,935 | Direct | |
| Sep 3, 2025 | Class A Ordinary Share | MOption exerciseDisposed | −15,026 | $0.00 | $0 | 44,974 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.